The aim of this study was to investigate the influence of body mass on auto
nomic nerve function in persons with type 2 diabetes. Towards this aim we s
tudied two groups of diabetic persons. Group 1: n = 30 lean (mean age 57.2
+/- 12.5 years, body mass index (BMI) 22.5 +/- 1.8 kg/m(2)]. Group 2: n = 3
5 overweight and obese (age 52.3 +/- 10.3 years, BMI 28.8 +/- 3.2 kg/m(2)).
Autonomic neuropathy (DAN) was assessed using the battery of the five clas
sical tests. DAN was diagnosed when at least two of the five tests were abn
ormal. Abnormalities of the heart rate based tests were considered as indic
ation of parasympathetic and of blood pressure changes as indication of sym
pathetic dysfunction. The prevalence rates of DAN were not different betwee
n group 2 and group 1 (54.2 and 53.3%, respectively, P = 0.54). The same wa
s valid for the rates of parasympathetic and sympathetic dysfunction in the
studied groups (51.4 and 53.3% (P = 0.87) in group 2 and 34.2 and 33.3% (P
= 0.93) in group 1, respectively). When the values of the arithmetic expre
ssion of each single autonomic function test were compared, no significant
difference could be shown between the studied groups. In addition, no signi
ficant correlation was found between BMI and indices of DAN. These data ind
icate that moderate increase of body mass does not affect autonomic functio
n in persons with type 2 diabetes. (C) 1999 Elsevier Science Ireland Ltd. A
ll rights reserved.